These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 31197556

  • 21. Effectiveness of Adjuvant Chemotherapy in Variant Histology Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy: Stabilized Inverse Probability Treatment Weighting Analysis of Single Center Experience.
    Park I, Suh J, Lim B, Song C, You D, Jeong IG, Hong JH, Ahn H, Cho YM, Lee J, Hong B.
    Clin Genitourin Cancer; 2024 Jun; 22(3):102069. PubMed ID: 38580522
    [Abstract] [Full Text] [Related]

  • 22. Prognostic Value of Lymphovascular Invasion in Node-Negative Upper Urinary Tract Urothelial Carcinoma Patients Undergoing Radical Nephroureterectomy.
    Liu W, Zhou Z, Dong D, Sun L, Zhang G.
    Yonsei Med J; 2019 Feb; 60(2):174-181. PubMed ID: 30666839
    [Abstract] [Full Text] [Related]

  • 23. Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.
    Chung HS, Hwang EC, Kim MS, Yu SH, Jung SI, Kang TW, Choi C, Choi SH, Kwon TG, Noh JH, Kim MK, Cho WJ, Kang SG, Kang SH, Cheon J, Seo IY, Chung H, Kim HS, Lee CH, Ku JY, Ha HK, Kim BH, Jeong CW, Ku JH, Kwak C, Kwon D.
    Clin Genitourin Cancer; 2019 Jun; 17(3):e394-e407. PubMed ID: 30782419
    [Abstract] [Full Text] [Related]

  • 24. Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration.
    Fairey AS, Kassouf W, Estey E, Tanguay S, Rendon R, Bell D, Izawa J, Chin J, Kapoor A, Matsumoto E, Black P, So A, Lattouf JB, Saad F, Drachenberg D, Cagiannos I, Lacombe L, Fradet Y, Jacobsen NE.
    BJU Int; 2013 Oct; 112(6):791-7. PubMed ID: 23148712
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
    Luo Y, Feng B, Wei D, Han Y, Li M, Zhao J, Lin Y, Hou Z, Jiang Y.
    Sci Rep; 2020 Oct 19; 10(1):17674. PubMed ID: 33077839
    [Abstract] [Full Text] [Related]

  • 27. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Kim KH, You D, Jeong IG, Hong JH, Ahn H, Kim CS.
    Urol Oncol; 2013 Nov 19; 31(8):1643-9. PubMed ID: 22591745
    [Abstract] [Full Text] [Related]

  • 28. Impact of body mass index on the oncological outcomes of patients with upper and lower urinary tract cancers treated with radical surgery: A multi-institutional retrospective study.
    Murakami Y, Matsumoto K, Ikeda M, Utsunomiya T, Hirayama T, Koguchi D, Matsuda D, Okuno N, Taoka Y, Irie A, Iwamura M.
    Asia Pac J Clin Oncol; 2018 Aug 19; 14(4):310-317. PubMed ID: 29356359
    [Abstract] [Full Text] [Related]

  • 29. Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study.
    Kang HW, Seo SP, Kim WT, Kim YJ, Yun SJ, Lee SC, Choi YD, Ha YS, Kim TH, Kwon TG, Byun SS, Jeh SU, Kim WJ.
    J Korean Med Sci; 2017 Feb 19; 32(2):335-342. PubMed ID: 28049247
    [Abstract] [Full Text] [Related]

  • 30. Pretreatment elevated fibrinogen level predicts worse oncologic outcomes in upper tract urothelial carcinoma.
    Xu H, Ai JZ, Tan P, Lin TH, Jin X, Gong LN, Lei HR, Yang L, Wei Q.
    Asian J Androl; 2020 Feb 19; 22(2):177-183. PubMed ID: 31169138
    [Abstract] [Full Text] [Related]

  • 31. Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.
    Kuroiwa K, Inokuchi J, Nishiyama H, Kojima T, Kakehi Y, Sugimoto M, Tanigawa T, Fujimoto H, Gotoh M, Masumori N, Ogawa O, Eto M, Ohyama C, Yokomizo A, Matsuyama H, Ichikawa T, Mizusawa J, Eba J, Naito S, JCOG UOSG.
    J Urol; 2019 Dec 19; 202(6):1127-1135. PubMed ID: 31251717
    [Abstract] [Full Text] [Related]

  • 32. High Infiltration of CD163-Positive Macrophages in Intratumor Compartment Predicts Poor Prognosis in Patients With Upper Urinary Tract Urothelial Carcinoma and Radical Nephroureterectomy.
    Kobayashi Y, Arai H, Hamamoto Y, Yoshida K, Shimizu S, Yasuhara Y, Ichimaru N.
    Clin Genitourin Cancer; 2023 Oct 19; 21(5):e386-e393. PubMed ID: 37244798
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of the Clinical Utility of Renin-Angiotensin System Inhibitors in Patients Undergoing Radical Surgery for Urothelial Carcinoma of the Upper Urinary Tract.
    Yoshida T, Matsuzaki T, Murota T, Kawa G, Matsuda T, Kinoshita H.
    Clin Genitourin Cancer; 2017 Dec 19; 15(6):e943-e954. PubMed ID: 28552573
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis.
    Quhal F, Mori K, Sari Motlagh R, Laukhtina E, Pradere B, Rouprêt M, Necchi A, Moschini M, Shariat SF.
    Int J Clin Oncol; 2020 Jun 19; 25(6):1037-1054. PubMed ID: 32206939
    [Abstract] [Full Text] [Related]

  • 35. Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Real-World, Retrospective Study.
    Lee J, Lim SH, Chung JH, Song W, Sung HH, Jeong BC, Park SH.
    Cancer Res Treat; 2024 Jul 19; 56(3):871-876. PubMed ID: 38228080
    [Abstract] [Full Text] [Related]

  • 36. Impact of surgical wait time on oncologic outcomes in upper urinary tract urothelial carcinoma.
    Lee JN, Kwon SY, Choi GS, Kim HT, Kim TH, Kwon TG, Kim BW.
    J Surg Oncol; 2014 Sep 19; 110(4):468-75. PubMed ID: 25059848
    [Abstract] [Full Text] [Related]

  • 37. Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT Trial.
    Birtle AJ, Jones R, Chester J, Lewis R, Biscombe K, Johnson M, Blacker A, Bryan RT, Catto JWF, Choudhury A, Das P, Jagdev S, Powles T, Wagstaff J, Cheung KC, Cafferty F, Hall E.
    J Clin Oncol; 2024 May 01; 42(13):1466-1471. PubMed ID: 38350047
    [Abstract] [Full Text] [Related]

  • 38. Effect of Lymphadenectomy During Radical Nephroureterectomy in Locally Advanced Upper Tract Urothelial Carcinoma.
    Ikeda M, Matsumoto K, Sakaguchi K, Ishii D, Tabata KI, Kurosawa K, Urakami S, Okaneya T, Iwamura M.
    Clin Genitourin Cancer; 2017 Oct 01; 15(5):556-562. PubMed ID: 28501481
    [Abstract] [Full Text] [Related]

  • 39. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma.
    Zhang XK, Zhang ZL, Yang P, Cai MY, Hu WM, Yun JP, Zhou FJ, Qian CN, Cao Y.
    Jpn J Clin Oncol; 2015 Nov 01; 45(11):1069-75. PubMed ID: 26355163
    [Abstract] [Full Text] [Related]

  • 40. Pathologic stage as a surrogate for oncologic outcomes after receipt of neoadjuvant chemotherapy for high-grade upper tract urothelial carcinoma.
    Singla N, Christie A, Freifeld Y, Ghandour RA, Woldu SL, Clinton TN, Petros FG, Robyak H, Yeh HC, Fang D, Enikeev D, Bagrodia A, Sagalowsky AI, Lotan Y, Raman JD, Matin SF, Margulis V.
    Urol Oncol; 2020 Dec 01; 38(12):933.e7-933.e12. PubMed ID: 32430254
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.